When p53 transcriptional activity in response to 5-FU treatment was measured, the mRNA and protein levels of p21, which is a p53 target gene, were decreased in the GST WT -p53-expressing cells
Athletes and biohackers pursuing musculoskeletal repair should understand that injectable use is now in a regulatory gray zone following the 2026 FDA Category 2 designation, making physician-supervised topical compounding the only currently legal route
BPC-157 has been studied extensively in preclinical models and has demonstrated meaningful effects on tissue repair, tendon and ligament healing, muscle recovery, wound healing, angiogenesis, nitric oxide signaling, inflammation modulation, and gastrointestinal mucosal protection
Spec table + per-test methodology available on the public COA page